10-K Decoder · All companies

ADMA Biologics, Inc.

ADMA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$510M$426M+19.6%
Operating income$191M$139M+37.7%
Net income$147M$198M−25.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$141M$134M+5.1%
Operating income$67.8M$51.0M+32.9%
Net income$49.9M$36.4M+37.1%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was ADMA Biologics's revenue in FY2025?
$510M in FY2025 (Fiscal year ended Dec 31, 2025), +19.6% vs $426M a year earlier, per its 10-K filed Feb 2026.
Was ADMA Biologics profitable in FY2025?
Yes: net income was $147M and operating income $191M in FY2025.
What was ADMA Biologics's revenue in Q3 2026?
$141M (+5.1% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.